News About: Pharm. Industry
Industries betting their business on new products this year.
Domestic drug industries are implementing strategies for the last year sales growth to be kept on this year too by adopting new product marketing projects to cope with compelling environmental changes possibly to caus...
Pfizer Korea's consumer teams to join Johnson & Johnson Korea
Teams of Nicorette and Rogaine are going to set up their full-fledged swing operations in Johnson & Johnson Korea, which is located at Yongsan.
Reportedly, Janssen Korea will be chiefly responsible for prescription...
Public advertising motivates market revival of OTC drugs.
Local drug industries have strengthened their public advertising for their OTC drugs to revive its market which once played as a major company revenue channel.
Having encountered with impending market competitions,...
Janssen loses patent dispute
The Seoul High Court on January 18 upheld a lower court ruling that dismissed a claim from Belgium-based Janssen Pharm that Whanin Pharm's Riperidone (risperidone) had
infringed on its patent.
Janssen first filed...
Mr. Hong Yu-seok named CEO of Lilly Korea as of Feb. 1.Mr. Hong Yu-seok (42 years old) has been nominated the chief executive officer of Lilly Korea as of Feb. 1, who was the Lilly's global marketing head on the osteoporosis therape...
|
Many impotence drugs compete in over saturated markets.
Under a slogan of "Expand the Market" Chongkungdang has launched a new impotence drug called "Yaila" into the already over saturated market after fully determining that only strategy for a new impotence drug success i...
J&J awarded Janssen Korea for 2006 best clinical research.
Janssen Korea has recognized its international competence in the clinical research works by receiving "the 2006 annual outstanding performance award" from its head office, J&J, which was appointed out of 49 internatio...
Handok's management, labor vow to promote company developmentWe are in full confidence for the company's 10-year vision and will empower our wage bargaining right to the company's representative director through union members' unanimous d...
|
Kang to accept third term
Kang Shin-ho, the incumbent chairman of the Federation of Korean Industries, expressed his willingness to accept another term.
Kang, chairman of Korea's top pharmaceutical company Dong-A, said on January 30 that if...
Pharmaceutical exports top $1.29 billion in 2006
Korea posted $1.29 billion in its drug export in 2006, up 13 percent compared with $1.15 billion a year earlier, while pharmaceutical imports in the same period surged to $4.4 billion, according to the Korea Pha...
